3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
141
Lung Neoplasms
51
Pancreatic Neoplasms
30
Non-Squamous Non-Small Cell Lung Cancer
18
Neoplasms
15
Adenocarcinoma of Lung
14
Head and Neck Neoplasms
13
Glioblastoma
13
Gliosarcoma
12
Breast Neoplasms
11
Brain Neoplasms
11
Neoplasm Metastasis
9
Carcinoma, Hepatocellular
9
Adenocarcinoma, Bronchiolo-Alveolar
9
Squamous Cell Carcinoma of Head and Neck
8
Carcinoma, Squamous Cell
7
Carcinoma, Renal Cell
7
Astrocytoma
6
Oligodendroglioma
5
Carcinoma
5
Urinary Bladder Neoplasms
4
Liver Neoplasms
4
Glioma
4
Esophageal Neoplasms
4
Colorectal Neoplasms
4
Adenocarcinoma
4
Recurrence
3
Rectal Neoplasms
3
Prostatic Neoplasms
3
Ovarian Neoplasms
3
Interventions
Dexamethasone
277
Lenalidomide
155
Bortezomib
152
Cyclophosphamide
115
Melphalan
107
Calcium Dobesilate
107
fludarabine phosphate
70
carfilzomib
61
pomalidomide
55
Peripheral Blood Stem Cell Transplantation
53
Whole-Body Irradiation
52
Mycophenolic Acid
52
Granulocyte Colony-Stimulating Factor
52
Filgrastim
52
daratumumab
46
fludarabine
43
Tacrolimus
41
ixazomib
40
Busulfan
40
Thalidomide
36
Cyclosporine
32
dexamethasone acetate
26
Stem Cell Transplantation
26
Antilymphocyte Serum
25
dexamethasone 21-phosphate
22
plerixafor
20
auricularum
20
belantamab mafodotin
19
Prednisone
19
Etoposide
19
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Multiple Myeloma
×
Erlotinib Hydrochloride
×
Clear all
No trials found.